EC Number |
Title |
Organism |
---|
2.7.1.154 | Characterization and mechanism of phosphoinositide 3-kinases (PI3Ks) members in insulin-induced changes of protein metabolism in yellow catfish Pelteobagrus fulvidraco |
Tachysurus fulvidraco |
2.7.1.154 | Class II phosphoinositide 3-kinases as novel drug targets |
Mus musculus |
2.7.1.154 | Class II phosphoinositide 3-kinases as novel drug targets |
Homo sapiens |
2.7.1.154 | Sevoflurane and isoflurane inhibit KCl-induced Class II phosphoinositide 3-kinase alpha subunit mediated vasoconstriction in rat aorta |
Rattus norvegicus |
2.7.1.154 | The class II phosphoinositide 3-kinases PI3K-C2alpha and PI3K-C2beta differentially regulate clathrin-dependent pinocytosis in human vascular endothelial cells |
Homo sapiens |
2.7.1.154 | A novel class II phosphoinositide 3-kinase predominantly expressed in the liver and its enhanced expression during liver regeneration |
Rattus norvegicus |
2.7.1.154 | Activation of phosphoinositide 3-kinase C2 beta in the nuclear matrix during compensatory liver growth |
Rattus norvegicus |
2.7.1.154 | Are class II posphoinositide 3-kinases potential targets for anticancer therapies? |
Homo sapiens |
2.7.1.154 | cDNA cloning of a third human C2-domain-containing class II phosphoinositide 3-kinase, PI3K-C2gamma, and chromosomal assignment of this gene (PIK3C2G) to 12p12 |
Homo sapiens |
2.7.1.154 | Class II phosphoinositide 3-kinase C2alpha regulates a novel signaling pathway involved in breast cancer progression |
Homo sapiens |